Red Light Therapy for Pain: 7 Kinds Tested, Filed as a Heat Lamp

Quick Answer: Red and near-infrared light has been tested against a sham for 7 kinds of pain: knee osteoarthritis, neck pain, low back pain, rheumatoid arthritis, fibromyalgia, diabetic nerve pain and muscle soreness after exercise. The strongest results, for the knee and the neck, come from lasers applied to painful spots in a clinic at defined doses. Low back pain results were small, and the one sham-controlled trial of a home infrared device for diabetic neuropathy found no difference from sham. Home devices are a different regulatory category: in FDA’s establishment database, 127 listings with “red light” in the product name sit under the code for an infrared therapeutic heating lamp, and 122 of them carry no 510(k) number, because that code has not needed one since 2019. The pain claim FDA has cleared for LED belts is heat: “elevating tissue temperature for a temporary relief of minor muscle and joint pain.”

Pain is one of the most searched uses of red light therapy, and most pages that answer it sell a panel, wrap or belt. This page goes condition by condition through the sham-controlled evidence, then reads the FDA records behind the devices. For the full list of red light uses, see our red light therapy benefits page; for what a home panel should disclose, see red light therapy at home.

The 7 kinds of pain, at a glance

Knee osteoarthritis: the dose decided the result

A 2019 meta-analysis in BMJ Open pooled 22 placebo-controlled trials with 1,063 people. Pain fell by 14.23 mm on a 100 mm visual analogue scale more than placebo at the end of treatment. In the trials that used doses recommended by the World Association for Laser Therapy, the difference was 18.71 mm, and it peaked at 31.87 mm two to four weeks after treatment ended. No adverse events were reported.

The conclusion names the dose: low-level laser therapy “reduces pain and disability in KOA at 4-8 J with 785-860 nm wavelength and at 1-3 J with 904 nm wavelength per treatment spot.” Those are near-infrared lasers aimed at specific points around the joint, not a red panel held at a distance. A home device that does not state its output at the skin gives you no way to know whether you are anywhere near that dose.

Neck pain: the largest effect, also from lasers

A 2009 meta-analysis in The Lancet found 16 randomised trials with 820 people. In chronic neck pain, five trials reporting categories of improvement gave a relative risk of 4.05 for pain improvement with laser therapy, and 11 trials reporting pain scores showed a reduction of 19.86 mm on a 100 mm scale. Relief lasted into follow-ups of up to 22 weeks, and side effects were mild and no different from placebo. The authors describe the treatment as “non-thermal laser irradiation … applied to sites of pain.”

Low back pain: real but small

Back pain is the condition most home wraps and belts are sold for, and its evidence is weaker than the knee or neck:

• The 2008 Cochrane review found seven trials. Three small studies with 168 people “showed statistically significant but clinically unimportant pain relief” against sham. Laser plus exercise was not better than exercise alone. The review concluded “there are insufficient data to draw firm conclusions.”
• A 2015 meta-analysis of seven placebo-controlled trials with 394 people found pain 13.57 mm lower on a 100 mm scale, but “No significant treatment effect was identified for disability scores or spinal range of motion.”

Both reviews are about lasers. We found no completed sham-controlled trial of a consumer LED back wrap reporting pain results.

Rheumatoid arthritis: short-term relief in the hands

The 2005 Cochrane review of rheumatoid arthritis included five placebo-controlled trials with 222 people. Laser therapy reduced pain by 1.10 points on a 10-point scale, shortened morning stiffness by 27.5 minutes and improved finger flexibility, while function, range of motion and swelling did not differ. The reviewers wrote that it “could be considered for short-term treatment,” and that the data could not say which wavelength, dose or treatment length works.

Fibromyalgia: no extra benefit on top of exercise

A 2019 meta-analysis found nine trials with 325 people with fibromyalgia. Against placebo laser, laser therapy improved pain, tender points, fatigue and the fibromyalgia questionnaire score. But “when compared with the standardized exercise program alone, LLLT plus the standardized exercise program provided no extra advantage.” The authors also note most trials were of “low-to-middle methodological quality,” with “only patients … blinded in most studies.”

Diabetic nerve pain: the home device trial that found nothing

This is the one condition where a sham-controlled trial tested a device used at home, and it is negative. In a double-blind trial published in Diabetes Care in 2008, 69 people with diabetic neuropathy used either an active or a sham Anodyne monochromatic infrared device at home for 40 minutes a day for 90 days. There were “no significant differences” in sensation tests, nerve conduction, quality of life or the neuropathy screening score. The authors concluded the therapy “was no more effective than sham therapy.”

Not everyone reads the field that way. A 2025 consensus statement in the Journal of the American Academy of Dermatology, produced by 21 experts chosen for their publication record, lists peripheral neuropathy among the conditions for which photobiomodulation “is an effective treatment option.” That is an expert-panel judgement, not a new trial. We are giving you both, because the trial that tested a home device against a sham is the one that most resembles what you would buy.

Muscle soreness: applied before exercise, in athletes

A 2022 meta-analysis of 24 studies in athletes found that laser therapy applied before exercise improved leg strength over the following days and reduced soreness and the muscle-damage marker creatine kinase. The authors wrote that “a definite therapeutic effect of LLLT is yet to be established” and asked for larger trials before strong recommendations. Most of these protocols are a pre-workout treatment, not lying under a panel after training.

What the FDA records say about home pain devices

The trials above are mostly about lasers. The devices sold for home pain relief are mostly LED wraps, belts, pads and panels, and their FDA paperwork tells a different story.

The pain claim FDA cleared is heat

When LED pain devices have gone through 510(k) clearance, it has usually been under product code ILY, “Lamp, Infrared, Therapeutic Heating.” The regulation behind it, 21 CFR 890.5500, defines the device as one that “emits energy at infrared frequencies … to provide topical heating.” The cleared wording for an LED pain belt shows what that means. LightStim for Pain LED Belt (K151333) is intended “to provide topical heating for the purpose of elevating tissue temperature for a temporary relief of minor muscle and joint pain and stiffness, minor arthritis pain or muscle spasm, the temporary increase in local blood circulation, and the temporary relaxation of muscles.”

Most red light devices under that code need no clearance at all

A December 2019 amendment made infrared therapeutic heating lamps exempt from the 510(k) premarket notification, subject to the general limitations on exemptions. The effect shows in FDA’s data:

• FDA’s 510(k) database holds 229 clearances under ILY. 55 came in 2012 to 2017; there have been 7 since 2020.
• FDA’s establishment registration and listing database (openFDA, data updated 12 October 2026) holds 612 device listings under ILY. 127 of them list a product with “red light” in its name, and 122 of those 127 carry no 510(k) number.
• 107 of the 127 are listed by establishments in China, and 93 were added in 2024 or later.

A listing is not a clearance. FDA’s own rule, 21 CFR 807.39, says registration “does not in any way denote approval of the establishment or its products,” and that “any representation that creates an impression of official approval because of registration … is misleading and constitutes misbranding.” If a seller says a device is “FDA registered” or “FDA listed,” ask which product code and whether there is a K-number. The lasers used in the stronger pain trials sit under different codes; FDA’s code NHN, for non-heating lasers for adjunctive use in pain therapy, has 54 clearances.

Heat on its own has evidence

That FDA files these devices as heat lamps is not a reason to dismiss them, because heat has its own trial record. A 2006 Cochrane review of superficial heat for low back pain found, in two trials with 258 people with acute and sub-acute back pain, that heat wrap therapy reduced pain after five days compared with an oral placebo, and in one trial a heated blanket lowered pain immediately. The reviewers called it “a small short-term reduction in pain and disability,” and noted that adding exercise helped further. What is not established is whether the red light in a heated wrap adds anything to the heat.

Who should see a doctor before trying light for pain

• Back pain with red flags: numbness in the groin or buttocks, new trouble controlling the bladder or bowel, leg weakness, fever, unexplained weight loss, a history of cancer, or pain after a fall or accident.
• Anyone with reduced feeling in the feet or legs, including diabetic neuropathy. Heated devices can burn skin you cannot feel, and heat lamps are among the burn reports covered on our red light therapy dangers page.
• A hot, swollen joint, which needs a diagnosis before any home treatment.
• Anyone taking a medicine that makes skin or eyes sensitive to light.

Frequently Asked Questions

Does red light therapy help with pain?

For some kinds of pain, in trials that used lasers at defined doses. The best results are for knee osteoarthritis (22 trials) and neck pain (16 trials). Results for low back pain were small, and a sham-controlled trial of a home infrared device for diabetic neuropathy found no difference from sham.

Is red light therapy good for back pain?

The evidence is modest. A 2008 Cochrane review found pain relief against sham that was “statistically significant but clinically unimportant,” and a 2015 meta-analysis found 13.57 mm less pain on a 100 mm scale with no improvement in disability. Both reviewed lasers. A 2006 Cochrane review found that heat wraps give a small short-term reduction in acute and sub-acute back pain.

Does red light therapy help knee pain?

For knee osteoarthritis, a 2019 meta-analysis of 22 trials found less pain than placebo, with the largest effect at specific doses: 4 to 8 joules per spot at 785 to 860 nm, or 1 to 3 joules at 904 nm. Those were lasers on treatment points around the knee. Home devices rarely state a dose you could compare.

Is red light therapy FDA approved for pain?

Some LED devices have been cleared, usually as infrared heating lamps for “temporary relief of minor muscle and joint pain” by elevating tissue temperature. Since 2019 that category has been exempt from 510(k) clearance, and 122 of 127 FDA listings with “red light” in the product name under that code have no 510(k) number. FDA says registration “does not in any way denote approval.”

Does red light therapy reduce inflammation?

The trials on this page mostly measured pain, not inflammation. In a 2022 meta-analysis of athletes, laser therapy before exercise lowered markers of muscle damage and the inflammatory signal interleukin-6. That is not evidence that a home panel reduces inflammation in arthritis or other conditions.

Does red light therapy help neuropathy?

The evidence conflicts. A double-blind 2008 trial of a home infrared device in 69 people with diabetic neuropathy found no difference from sham after 90 days. A 2025 consensus statement by 21 experts lists peripheral neuropathy as a condition where photobiomodulation is effective. People with neuropathy should be careful with heated devices because of the burn risk.

The Bottom Line

Red and near-infrared light has been tested against a sham for at least seven kinds of pain, and the strongest results, for knee osteoarthritis and neck pain, come from clinic lasers at stated doses. Back pain results are small, and the one sham-controlled trial of a home infrared device, for diabetic neuropathy, found nothing. Most red light devices sold for home pain are listed with FDA as infrared heating lamps, a category that has needed no 510(k) since 2019, and the pain claim FDA has cleared for LED belts is heat. Heat has modest evidence for short-term back pain on its own. If you buy a device, buy it knowing that, and ask the seller for a product code and K-number rather than accepting “FDA registered.”

Sources

1. Stausholm MB, et al. Efficacy of low-level laser therapy on pain and disability in knee osteoarthritis: systematic review and meta-analysis of randomised placebo-controlled trials. BMJ Open, 2019;9(10):e031142. PMID 31662383. 22 trials, n=1063; pain 14.23 mm (95% CI 7.31 to 21.14) at end of therapy; recommended doses 18.71 mm, peak 31.87 mm at 2 to 4 weeks; “reduces pain and disability in KOA at 4-8 J with 785-860 nm wavelength and at 1-3 J with 904 nm wavelength per treatment spot.” Checked 22 October 2026.
2. Chow RT, Johnson MI, Lopes-Martins RA, Bjordal JM. Efficacy of low-level laser therapy in the management of neck pain: a systematic review and meta-analysis of randomised placebo or active-treatment controlled trials. Lancet, 2009;374(9705):1897-1908. PMID 19913903. 16 RCTs, 820 patients; chronic neck pain RR 4.05 (2.74 to 5.98) in 5 trials; VAS reduced 19.86 mm (10.04 to 29.68) in 11 trials; 22.07 mm at follow-up of 1 to 22 weeks. Checked 22 October 2026.
3. Yousefi-Nooraie R, et al. Low level laser therapy for nonspecific low-back pain. Cochrane Database Syst Rev, 2008;(2):CD005107. PMID 18425909. 7 RCTs; 3 studies (168 people) “statistically significant but clinically unimportant pain relief”; “insufficient data to draw firm conclusions.” Checked 22 October 2026.
4. Huang Z, et al. The effectiveness of low-level laser therapy for nonspecific chronic low back pain: a systematic review and meta-analysis. Arthritis Res Ther, 2015;17:360. PMID 26667480. 7 RCTs, 394 patients; VAS WMD -13.57 (95% CI -17.42 to -9.72) from 5 studies; no significant effect on disability or range of motion. Checked 22 October 2026.
5. Brosseau L, et al. Low level laser therapy (Classes I, II and III) for treating rheumatoid arthritis. Cochrane Database Syst Rev, 2005;(4):CD002049. PMID 16235295. 5 placebo-controlled trials, 222 patients; pain -1.10 points (10-point VAS), morning stiffness -27.5 minutes; “could be considered for short-term treatment.” Checked 22 October 2026.
6. Yeh SW, et al. Low-level laser therapy for fibromyalgia: a systematic review and meta-analysis. Pain Physician, 2019;22(3):241-254. PMID 31151332. 9 RCTs, 325 patients; benefit versus placebo laser; “LLLT plus the standardized exercise program provided no extra advantage”; “low-to-middle methodological quality.” Checked 22 October 2026.
7. Lavery LA, Murdoch DP, Williams J, Lavery DC. Does anodyne light therapy improve peripheral neuropathy in diabetes? A double-blind, sham-controlled, randomized trial to evaluate monochromatic infrared photoenergy. Diabetes Care, 2008;31(2):316-321. PMID 17977931. 69 randomised, 60 completed; home use 40 minutes daily for 90 days; “no significant differences”; “no more effective than sham therapy.” Checked 22 October 2026.
8. Maghfour J, et al. Evidence-based consensus on the clinical application of photobiomodulation. J Am Acad Dermatol, 2025;93(2):429-443. PMID 40253006. Panel of 21 experts “assembled based on publication history”; lists peripheral neuropathy among conditions where PBM “is an effective treatment option.” Checked 22 October 2026.
9. Luo WT, Lee CJ, Tam KW, Huang TW. Effects of low-level laser therapy on muscular performance and soreness recovery in athletes: a meta-analysis of randomized controlled trials. Sports Health, 2022;14(5):687-693. PMID 34428975. 24 studies; LLLT before exercise improved strength and reduced soreness, creatine kinase and IL-6; “a definite therapeutic effect of LLLT is yet to be established.” Checked 22 October 2026.
10. French SD, Cameron M, Walker BF, Reggars JW, Esterman AJ. Superficial heat or cold for low back pain. Cochrane Database Syst Rev, 2006;(1):CD004750. PMID 16437495. 9 trials, 1,117 participants; heat wrap reduced pain at 5 days in 2 trials (258 people) versus oral placebo; “a small short-term reduction in pain and disability.” Checked 22 October 2026.
11. U.S. Code of Federal Regulations, 21 CFR 890.5500, Infrared lamp. eCFR. “emits energy at infrared frequencies (approximately 700 nanometers to 50,000 nanometers) to provide topical heating”; infrared therapeutic heating lamp exempt from premarket notification (amended 84 FR 71818, 30 December 2019). Checked 22 October 2026.
12. U.S. Code of Federal Regulations, 21 CFR 807.39, Misbranding by reference to establishment registration or to registration number. eCFR. “does not in any way denote approval of the establishment or its products.” Checked 22 October 2026.
13. U.S. Food and Drug Administration. 510(k) K151333, LightStim for Pain LED Belt, Indications for Use. FDA PDF. “to provide topical heating for the purpose of elevating tissue temperature for a temporary relief of minor muscle and joint pain and stiffness.” Checked 22 October 2026.
14. openFDA device 510(k) and registration and listing endpoints, product codes ILY and NHN. openFDA. ILY: 229 510(k) clearances (55 in 2012 to 2017, 7 since 2020); 612 listings, 127 with “red light” in a proprietary name, 122 of those without a 510(k) number, 107 from establishments in China, 93 created 2024 or later (data updated 12 October 2026). NHN: 54 clearances. No 510(k) under FliKEZE or NeoBack. Our counts, 22 October 2026.